Literature DB >> 11865551

[Neurofibromatosis 1: recommendations for management].

S Pinson1, A Créange, S Barbarot, J F Stalder, Y Chaix, D Rodriguez, M Sanson, A Bernheim, M d'Incan, F Doz, C Stoll, P Combemale, C Kalifa, J Zeller, D Teillac-Hamel, S Lyonnet, M Zerah, J P Lacour, B Guillot, P Wolkenstein.   

Abstract

Twenty experts, members of a French medical network devoted to neurofibromatosis 1 have elaborated recommendations for the management of the disease. Bibliography was obtained through a Medline of articles from 1966 to 1999 for the terms neurofibromatosis, NF1, neurofibroma and from textbooks. A consensual document was written taking into account extracted data. An annual careful clinical examination is recommended except in cases with complications. Screening investigations are not recommended due to the rarity of complications, generally symptomatic and easily detected during the clinical follow-up. The only controversial exception might be magnetic resonance imaging for early detection of optic pathway gliomas in young children. A co-ordinated follow-up in specialised multidisciplinary centres, providing patients with a rational management, is recommended.

Entities:  

Mesh:

Year:  2002        PMID: 11865551     DOI: 10.1016/s0929-693x(01)00695-9

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  8 in total

Review 1.  Pediatric brain MRI in neurofibromatosis type I.

Authors:  Hans-J Mentzel; Jörg Seidel; Clemens Fitzek; Annegret Eichhorn; Susanna Vogt; Jürgen R Reichenbach; Felix Zintl; Werner A Kaiser
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.

Authors:  Victor-F Mautner; Florence A Asuagbor; Eva Dombi; Carsten Fünsterer; Lan Kluwe; Ralf Wenzel; Brigitte C Widemann; Jan M Friedman
Journal:  Neuro Oncol       Date:  2008-06-17       Impact factor: 12.300

3.  Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.

Authors:  Claire-Marie Legendre; Catherine Charpentier-Côté; Régen Drouin; Chantal Bouffard
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

4.  A case report of cervical neurofibrosarcoma: Clinical presentation, treatment and outcome.

Authors:  Asmaou Dalil; Valentin Fokouo Fogha; Jean Evehe Vokwely; Emery Sougou; Jérôme Miloundja
Journal:  Int J Surg Case Rep       Date:  2017-12-12

5.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

6.  [Clinical aspects of Neurofibromatosis type 1 seen in the Department of Dermatology at University Hospital Antananarivo, Madagascar].

Authors:  Fandresena Arilala Sendrasoa; Aurélie Rasoarisata; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  Med Trop Sante Int       Date:  2022-05-27

7.  A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course.

Authors:  Suma Ganesh; Archana Gupta; Manish Sharma; Sandeep Bhuttan
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

8.  Plexiform neurofibroma of the wrist: imaging features and when to suspect malignancy.

Authors:  Maria Gosein; Anthony Ameeral; Renee Banfield; Murrie Mosodeen
Journal:  Case Rep Radiol       Date:  2013-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.